C J Ferro
Affiliation: University Hospital Birmingham
- The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolStephanie Stringer
Department of Nephrology, University Hospital Birmingham, Birmingham B15 2WB, UK
BMC Nephrol 14:95. 2013..Accurate mapping of the bio-clinical determinants of this group will enable improved risk stratification and direct the development of better targeted management for people with CKD...
- Cardiovascular effects of sevelamer in stage 3 CKDColin D Chue
Schools of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom
J Am Soc Nephrol 24:842-52. 2013..In conclusion, this study does not provide evidence that sevelamer carbonate improves LV mass, LV function, or arterial stiffness in stage 3 nondiabetic CKD...
- Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trialColin D Chue
Department of Nephrology, Queen Elizabeth Hospital and University of Birmingham, Birmingham, UK
Trials 12:30. 2011..TRIAL REGISTRATION: This trial is registered at ClinicalTrials.gov: NCT00806481 and Current Controlled Trials: ISRCTN35254279...
- Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational studyCharles J Ferro
Department of Nephrology, University of Birmingham and University Hospital Birmingham, Birmingham, UK
Hypertens Res 34:113-9. 2011..5 ± 1.8 vs. 8.8 ± 1.9 m s(-1); P = 0.02). This study suggests that immunosuppression might be a method of reducing blood pressure and arterial stiffness in patients with chronic kidney disease...
- Is lowering phosphate exposure the key to preventing arterial stiffening with age?C J Ferro
Department of Nephrology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, West Midlands B15 2TH, UK
Heart 95:1770-2. 2009..It is hypothesised that reducing phosphate intake will attenuate the progression of arterial stiffness with major beneficial effects upon cardiovascular mortality and morbidity...
- Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance studyColin D Chue
Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, UK
Heart 98:219-24. 2012..To explore the relationship between serum phosphate, arterial stiffness and left ventricular mass (LVM) in patients with early-stage chronic kidney disease (CKD)...
- Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?W E Moody
Department of Cardiovascular Medicine, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK
J Hum Hypertens 26:141-8. 2012....
- Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fractionN C Edwards
Department of Cardiology, University of Birmingham and University Hospital Birmingham, Birmingham, UK
Heart 94:1038-43. 2008..To examine arterial and left ventricular function and their interaction in patients with early-stage chronic kidney disease (CKD)...
- The treatment of coronary artery disease in patients with chronic kidney diseaseN C Edwards
Research Fellow in Cardiology, Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK
QJM 99:723-36. 2006..The high rate of late adverse cardiovascular events after both CABG and angioplasty accentuates the need for effective secondary preventive therapy disease in these high-risk patients...
- Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney diseaseColin D Chue
Department of Cardiology, Queen Elizabeth Hospital, Birmingham and University of Birmingham, Birmingham, UK
Nephrol Dial Transplant 26:2576-82. 2011..We sought to determine whether serum phosphate and markers of arterial stiffness predict progression of renal dysfunction in patients with early CKD...